C250H142N38O14 — CID 158534687
2-[4-[4,6-bis(2,6-dipyridin-2-yl-4-pyridinyl)-1,3,5-triazin-2-yl]phenyl]-1,3-benzoxazole;2-[4-[4,6-bis[3,5-di(pyrimidin-5-yl)phenyl]-1,3,5-triazin-2-yl]phenyl]-1,3-benzoxazole;2-[4-[4,6-di(dibenzofuran-1-yl)-1,3,5-triazin-2-yl]phenyl]-1,3-benzoxazole;2-[4-[4,6-di(dibenzofuran-2-yl)-1,3,5-triazin-2-yl]phenyl]-1,3-benzoxazole;2-[4-[4,6-di(dibenzofuran-3-yl)-1,3,5-triazin-2-yl]phenyl]-1,3-benzoxazole;2-[4-[4,6-di(dibenzofuran-4-yl)-1,3,5-triazin-2-yl]phenyl]-1,3-benzoxazole (PubChem CID 158534687) has the molecular formula C250H142N38O14 and a molecular weight of 3902.14 g/mol. Its IUPAC name is 2-[4-[4,6-bis(2,6-dipyridin-2-yl-4-pyridinyl)-1,3,5-triazin-2-yl]phenyl]-1,3-benzoxazole;2-[4-[4,6-bis[3,5-di(pyrimidin-5-yl)phenyl]-1,3,5-triazin-2-yl]phenyl]-1,3-benzoxazole;2-[4-[4,6-di(dibenzofuran-1-yl)-1,3,5-triazin-2-yl]phenyl]-1,3-benzoxazole;2-[4-[4,6-di(dibenzofuran-2-yl)-1,3,5-triazin-2-yl]phenyl]-1,3-benzoxazole;2-[4-[4,6-di(dibenzofuran-3-yl)-1,3,5-triazin-2-yl]phenyl]-1,3-benzoxazole;2-[4-[4,6-di(dibenzofuran-4-yl)-1,3,5-triazin-2-yl]phenyl]-1,3-benzoxazole.
| Compound Name | 2-[4-[4,6-bis(2,6-dipyridin-2-yl-4-pyridinyl)-1,3,5-triazin-2-yl]phenyl]-1,3-benzoxazole;2-[4-[4,6-bis[3,5-di(pyrimidin-5-yl)phenyl]-1,3,5-triazin-2-yl]phenyl]-1,3-benzoxazole;2-[4-[4,6-di(dibenzofuran-1-yl)-1,3,5-triazin-2-yl]phenyl]-1,3-benzoxazole;2-[4-[4,6-di(dibenzofuran-2-yl)-1,3,5-triazin-2-yl]phenyl]-1,3-benzoxazole;2-[4-[4,6-di(dibenzofuran-3-yl)-1,3,5-triazin-2-yl]phenyl]-1,3-benzoxazole;2-[4-[4,6-di(dibenzofuran-4-yl)-1,3,5-triazin-2-yl]phenyl]-1,3-benzoxazole |
|---|---|
| PubChem CID | 158534687 |
| Molecular Formula | C250H142N38O14 |
| Molecular Weight | 3902.14 g/mol |
| Exact Mass | 3899.16 |
| IUPAC Name | 2-[4-[4,6-bis(2,6-dipyridin-2-yl-4-pyridinyl)-1,3,5-triazin-2-yl]phenyl]-1,3-benzoxazole;2-[4-[4,6-bis[3,5-di(pyrimidin-5-yl)phenyl]-1,3,5-triazin-2-yl]phenyl]-1,3-benzoxazole;2-[4-[4,6-di(dibenzofuran-1-yl)-1,3,5-triazin-2-yl]phenyl]-1,3-benzoxazole;2-[4-[4,6-di(dibenzofuran-2-yl)-1,3,5-triazin-2-yl]phenyl]-1,3-benzoxazole;2-[4-[4,6-di(dibenzofuran-3-yl)-1,3,5-triazin-2-yl]phenyl]-1,3-benzoxazole;2-[4-[4,6-di(dibenzofuran-4-yl)-1,3,5-triazin-2-yl]phenyl]-1,3-benzoxazole |
| SMILES | c1ccc(-c2cc(-c3nc(-c4ccc(-c5nc6ccccc6o5)cc4)nc(-c4cc(-c5ccccn5)nc(-c5ccccn5)c4)n3)cc(-c3ccccn3)n2)nc1.c1ccc2oc(-c3ccc(-c4nc(-c5cc(-c6cncnc6)cc(-c6cncnc6)c5)nc(-c5cc(-c6cncnc6)cc(-c6cncnc6)c5)n4)cc3)nc2c1.c1ccc2oc(-c3ccc(-c4nc(-c5ccc6c(c5)oc5ccccc56)nc(-c5ccc6c(c5)oc5ccccc56)n4)cc3)nc2c1.c1ccc2oc(-c3ccc(-c4nc(-c5ccc6oc7ccccc7c6c5)nc(-c5ccc6oc7ccccc7c6c5)n4)cc3)nc2c1.c1ccc2oc(-c3ccc(-c4nc(-c5cccc6c5oc5ccccc56)nc(-c5cccc6c5oc5ccccc56)n4)cc3)nc2c1.c1ccc2oc(-c3ccc(-c4nc(-c5cccc6oc7ccccc7c56)nc(-c5cccc6oc7ccccc7c56)n4)cc3)nc2c1 |
| InChI | InChI=1S/C46H28N10O.C44H26N12O.4C40H22N4O3/c1-2-16-42-37(15-1)53-46(57-42)30-19-17-29(18-20-30)43-54-44(31-25-38(33-11-3-7-21-47-33)51-39(26-31)34-12-4-8-22-48-34)56-45(55-43)32-27-40(35-13-5-9-23-49-35)52-41(28-32)36-14-6-10-24-50-36;1-2-4-40-39(3-1)53-44(57-40)28-7-5-27(6-8-28)41-54-42(33-11-29(35-15-45-23-46-16-35)9-30(12-33)36-17-47-24-48-18-36)56-43(55-41)34-13-31(37-19-49-25-50-20-37)10-32(14-34)38-21-51-26-52-22-38;1-4-16-32-25(9-1)27-11-7-13-29(35(27)45-32)38-42-37(23-19-21-24(22-20-23)40-41-31-15-3-6-18-34(31)47-40)43-39(44-38)30-14-8-12-28-26-10-2-5-17-33(26)46-36(28)30;1-4-14-30-25(9-1)35-27(11-7-17-33(35)45-30)38-42-37(23-19-21-24(22-20-23)40-41-29-13-3-6-16-32(29)47-40)43-39(44-38)28-12-8-18-34-36(28)26-10-2-5-15-31(26)46-34;1-4-10-32-27(7-1)29-21-25(17-19-34(29)45-32)38-42-37(23-13-15-24(16-14-23)40-41-31-9-3-6-12-36(31)47-40)43-39(44-38)26-18-20-35-30(22-26)28-8-2-5-11-33(28)46-35;1-4-10-32-27(7-1)29-19-17-25(21-35(29)45-32)38-42-37(23-13-15-24(16-14-23)40-41-31-9-3-6-12-34(31)47-40)43-39(44-38)26-18-20-30-28-8-2-5-11-33(28)46-36(30)22-26/h1-28H;1-26H;4*1-22H |
| InChIKey | HNUJNSOIWCAWIR-UHFFFAOYSA-N |
| XLogP | 60.15 |
| TPSA | 673.78 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 52 |
| Rotatable Bonds | 32 |
| Heavy Atoms | 302 |
| Complexity | — |
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 3902.14 |
| LogP ≤ 5 | 60.15 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 52 |